c-Mpl as a Marker for Human Stem Cells
Author Information
Author(s): Ninos John M, Jefferies Leigh C, Cogle Christopher R, Kerr William G
Primary Institution: H. Lee Moffitt Cancer Center and Research Institute
Hypothesis
The TPO receptor, c-mpl, is a selective surface marker for human hematopoietic stem cells.
Conclusion
The study shows that c-mpl is expressed at the highest levels on the most primitive human hematopoietic stem cells, indicating its potential as a marker for identifying and isolating these cells.
Supporting Evidence
- c-mpl expression was highest in the most primitive stage I HSC/PC across all tissue sources.
- The percentage of c-mpl+ cells decreased significantly from stage I to stage IV.
- c-mpl+ cells showed higher levels of donor HLA+ thymocyte reconstitution compared to c-mpl- cells.
Takeaway
Scientists found that a special marker called c-mpl is found mostly on the earliest and most important blood-making cells in humans, which helps in understanding how to find and use these cells for treatments.
Methodology
Flow cytometry was used to analyze c-mpl expression in different stages of human CD34+ hematopoietic stem/progenitor cells from various sources.
Limitations
The study did not explore the functional differences between c-mpl+ and c-mpl- cells in detail.
Participant Demographics
Human samples were obtained from fetal liver, umbilical cord blood, adult bone marrow, and mobilized peripheral blood stem cells.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website